Quentin Belle
About Quentin Belle
Quentin Belle is a Product Manager at Bristol Myers Squibb in Rueil-Malmaison, Île-de-France, France, with extensive experience in the pharmaceutical industry, particularly in neurology and cardiology.
Current Position at Bristol Myers Squibb
Quentin Belle is currently working as a Product Manager at Bristol Myers Squibb. He started this role in August 2022 and is based in Rueil-Malmaison, Île-de-France, France. In his current position, Quentin focuses on the management of products related to neurology and cardiology, leveraging his extensive background in health, life sciences, and new technologies.
Previous Role at Celgene
Before joining Bristol Myers Squibb, Quentin Belle worked at Celgene as a Product Manager in the Multiple Sclerosis division from 2020 to 2022. Located in Paris La Défense, Île-de-France, France, his role focused on the strategic management and market introduction of multiple sclerosis products.
Experience at Biogen
Quentin Belle has extensive experience at Biogen, having held multiple roles. Between 2016 and 2019, he served as Assistant Product Manager for Multiple Sclerosis and Biosimilars, Project Manager Jr. for Spinal Muscular Atrophy, and Product Manager for Spinal Muscular Atrophy. His responsibilities included project execution and product management, with a focus on neurology.
Educational Background
Quentin Belle has a solid educational foundation, having studied at Université Paris-Saclay. He earned a Master 2 (M2) in Marketing of Innovation from 2016 to 2017 and a Master 1 in Neuroscience from 2015 to 2016. Additionally, Quentin holds a Licence in Chemistry, which he completed from 2012 to 2013.
Early Career and Retail Experience
Before transitioning to the pharmaceutical industry, Quentin Belle worked in retail as an Assistant vente at Carrefour. He held this role for three years, from 2013 to 2016, in Les Ulis, Île-de-France, France. This early career experience provided Quentin with valuable customer service and sales skills that he later applied in his roles in the pharmaceutical sector.